School of Life Science, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan, 102488, Beijing, China.
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan, 102488, Beijing, China.
Biomed Pharmacother. 2020 Sep;129:110479. doi: 10.1016/j.biopha.2020.110479. Epub 2020 Jul 10.
Radix astragali, a medicinal material for tonifying Chinese Qi, has widely been used for the treatment of Kidney disease in China and East Asia, especially in reducing the apoptosis of glomerular podocytes. Paecilomyces Cicadidae is a medicinal and edible fungus. In recent years, the application of traditional Chinese medicine (TCM) in solid-state fermentation of edible and medicinal fungi has become a hot issue. Fermentation is a special method to change the properties of TCM. Therefore, the potential roles and molecular mechanisms on podocytes of solid-state fermentation products of Radix astragali and Paecilomyces cicadidae (RPF) in diabetic nephropathy (DN) were studied. In vivo, the effect of RPF and Radix astragali on DN in mice was evaluated by detecting the biochemical indexes of blood and urine, renal function and podocyte integrity. In vitro, the expression of podocyte marker protein, autophagy marker protein and PI3K/AKT/mTOR signaling pathway protein were detected by Western blotting using a high glucose-induced podocyte injury model. The results showed that RPF had a significant alleviative effect on DN mice. RPF can significantly reduce urine protein, serum creatinine, and blood nitrogen urea in DN mice. Morphological analysis showed that RPF could improve kidney structure of DN and reduce the apoptosis of podocytes, and the effect was better than Radix astragali. In vitro results indicated that RPF could enhance autophagy and protect podocytes by inhibiting the PI3K/AKT/mTOR signaling pathway. In summary, RPF has better effect on delaying the development of DN than Radix astragali. RPF enhances autophagy in podocytes and delays DN probably by inhibiting the PI3K/AKT/mTOR signaling pathway.
黄芪,一种用于补气的中药材,在中国和东亚被广泛用于治疗肾病,特别是减少肾小球足细胞的凋亡。蝉拟青霉是一种药食两用真菌。近年来,中药(TCM)在药用和食用真菌固态发酵中的应用成为热点。发酵是改变中药特性的特殊方法。因此,研究了黄芪和蝉拟青霉(RPF)固态发酵产物对糖尿病肾病(DN)中足细胞的潜在作用和分子机制。在体内,通过检测血液和尿液的生化指标、肾功能和足细胞完整性,评估 RPF 和黄芪对糖尿病肾病小鼠的影响。在体外,通过高糖诱导的足细胞损伤模型,用 Western blot 检测足细胞标记蛋白、自噬标记蛋白和 PI3K/AKT/mTOR 信号通路蛋白的表达。结果表明,RPF 对糖尿病肾病小鼠有显著的缓解作用。RPF 可显著降低糖尿病肾病小鼠的尿蛋白、血清肌酐和血尿素氮。形态学分析表明,RPF 可改善糖尿病肾病小鼠的肾脏结构,减少足细胞凋亡,效果优于黄芪。体外结果表明,RPF 通过抑制 PI3K/AKT/mTOR 信号通路增强自噬并保护足细胞。综上所述,RPF 对延缓糖尿病肾病的发展有更好的效果。RPF 通过抑制 PI3K/AKT/mTOR 信号通路增强足细胞自噬,从而延缓糖尿病肾病的发生。
J Med Microbiol. 2022-5
J Diabetes Res. 2019-12-7
Front Endocrinol (Lausanne). 2025-7-8
Front Pharmacol. 2024-8-26
Diabetes Metab Syndr Obes. 2024-7-22
Front Pharmacol. 2024-6-14